ELL3
RNA polymerase II elongation factor ELL3
Also known as: ELL3_HUMAN, FLJ22637
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HB65
- Gene
- ELL3
- Ensembl
- ENSG00000128886
- Chromosome
- 15
- Canonical length
- 397 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Mitotic chromosome
OverviewNCBI Gene
Predicted to enable cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of DNA-templated transcription and transcription by RNA polymerase II. Located in several cellular components, including chromosome; cytosol; and nuclear lumen. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
397 residues, UniProt reviewed canonical sequence.
>Q9HB65|ELL3
1 MEELQEPLRG QLRLCFTQAA RTSLLLLRLN DAALRALQEC QRQQVRPVIA FQGHRGYLRL
61 PGPGWSCLFS FIVSQCCQEG AGGSLDLVCQ RFLRSGPNSL HCLGSLRERL IIWAAMDSIP
121 APSSVQGHNL TEDARHPESW QNTGGYSEGD AVSQPQMALE EVSVSDPLAS NQGQSLPGSS
181 REHMAQWEVR SQTHVPNREP VQALPSSASR KRLDKKRSVP VATVELEEKR FRTLPLVPSP
241 LQGLTNQDLQ EGEDWEQEDE DMDPRLEHSS SVQEDSESPS PEDIPDYLLQ YRAIHSAEQQ
301 HAYEQDFETD YAEYRILHAR VGTASQRFIE LGAEIKRVRR GTPEYKVLED KIIQEYKKFR
361 KQYPSYREEK RRCEYLHQKL SHIKGLILEF EEKNRGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 54 nTPM
- lymph node: 48 nTPM
- skin: 25 nTPM
- duodenum: 16 nTPM
- testis: 16 nTPM
- choroid plexus: 15 nTPM
Single-cell type
- choroid plexus epithelial cells: 6.9 nCPM
- enterocytes: 2.7 nCPM
- enteric transient amplifying cells: 1.8 nCPM
- parietal cells: 1.8 nCPM
- colonocytes: 1.3 nCPM
- ependymal cells: 1.2 nCPM
Immune cell
- naive B-cell: 17 nTPM
- memory B-cell: 11 nTPM
- plasmacytoid DC: 3.2 nTPM
- naive CD4 T-cell: 1.3 nTPM
- memory CD4 T-cell: 1 nTPM
- total PBMC: 0.9 nTPM
Brain region
- choroid plexus: 11 nTPM
- hypothalamus: 1.4 nTPM
- midbrain: 0.8 nTPM
- hippocampal formation: 0.7 nTPM
- medulla oblongata: 0.7 nTPM
- white matter: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA-templated transcription elongation
- intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- neural precursor cell proliferation
- positive regulation of DNA-templated transcription, elongation
- positive regulation of neural precursor cell proliferation
- positive regulation of neurogenesis
- positive regulation of stem cell proliferation
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription elongation by RNA polymerase II
- regulation of epithelial to mesenchymal transition
- snRNA transcription by RNA polymerase II
- spermatogenesis
- stem cell differentiation
- stem cell proliferation
- transcription by RNA polymerase II
- transcription elongation by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ELL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELL3 as an antibody target. Whether an autoantibody or antibody against ELL3 could matter depends on whether native ELL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...